# cbdMD, Inc. (YCBD) · Edgar & Edgarette company card

> cbdMD (YCBD) saw revenue fall 3.7% in FY2025 to $19 million, operating margin -11.3% against a 3.3% median for perfumes, cosmetics & other toilet preparations, equity 69.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1644903 · fiscal year ended 2025-09-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/YCBD) · [JSON](https://www.pops4.com/boards/company/YCBD.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $19M |
| Revenue growth, 1 year | -3.7% |
| Revenue growth per year | -20.2% |
| Operating margin | -11.3% (prior year -16.6%) |
| Net margin | -10.6% |
| Operating cash flow | −$1M |
| Capital spending | $184,172 |
| Free cash flow | −$2M |
| Cash | $2M |
| Long-term debt | — |
| Total assets | $10M |
| Total equity | $7M |
| Equity ÷ assets | 69.3% |
| Return on equity | -28.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -53.04 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · slow and jumpy: growing slower than its size class, with revenue that swings more; operating cash flow was negative; operating loss: a margin of -11.3% in FY2025; revenue is hard to predict: its 80% range is ±57%
- Cash Compass: Fading · slow and jumpy, lagging its peers

## Edgarette's reading

Exposure: revenue $19.2M (FY2025). Experience: revenue down 3.7% on the year, down 20.2% a year over 4 years; operating margin -11.3%, up from -16.6%. Soundness: equity 69.3% of assets, return on equity -28.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $8.7M and $31.7M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $8.0M to $34.8M. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, perfumes, cosmetics & other toilet preparations): operating margin -11.3% against a 3.3% median; growth -3.7% against 0.1%.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-04-01 ([filing](https://www.sec.gov/Archives/edgar/data/1644903/000143774926010878/0001437749-26-010878-index.htm))

## Recent filings

- 8-K · filed 2026-11-04 · 2.01 Completion of Acquisition or Disposition of Assets; 2.03 Creation of a Direct Financial Obligation; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1644903/000143774926034991/0001437749-26-034991-index.htm)
- 8-K · filed 2026-09-02 · 1.01 Entry into a Material Definitive Agreement; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1644903/000143774926029455/0001437749-26-029455-index.htm)
- 10-Q · filed 2026-08-13 · [filing](https://www.sec.gov/Archives/edgar/data/1644903/000143774926027665/0001437749-26-027665-index.htm)
- 8-K · filed 2026-05-20 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1644903/000143774926017970/0001437749-26-017970-index.htm)
- 10-Q · filed 2026-05-14 · [filing](https://www.sec.gov/Archives/edgar/data/1644903/000143774926017042/0001437749-26-017042-index.htm)
- 8-K · filed 2026-04-15 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1644903/000143774926012392/0001437749-26-012392-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001644903.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1644903

## Cite

POPS4, Edgar & Edgarette: cbdMD, Inc. (YCBD) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/YCBD. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

